Janssen Search
Search results
New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)
Mar 05, 2023 United States Findings presented at ACC.23 show XARELTO ® plus aspirin provides a 33 percent reduction in acute limb ischemia following LER, with consistent benefit demonstrated at 30 days, 90 days and up to three years Patients who undergo ...
Precision Medicine Glossary
Precision Medicine Glossary The list below is not intended to be an exhaustive compendium of precision medicine (PM) terminology, but seeks to explain many terms used on our site and other vehicles that discuss this field. Biomarker: A biological molecule ...
Other Focus Areas
Other Focus Areas We are dedicated to advancing health around the world. Structure of Ebola virus As a leader in the field of global health, we seek ways to use our business expertise and global footprint to ensure access needs are met around the world. ...
Ai Drug Design Generative Modeling
The chemical space for drug-like compounds is so vast that it can barely be comprehended. By leveraging artificial intelligence (AI) principles, we can more intelligently search through this space and evaluate millions of compounds for multiple desired ...
Janssen Healthy Minds Videos Tackle Mental Health Stigma
Janssen Healthy Minds Videos Tackle Mental Health Stigma Article Type: Neuroscience Article Block Text: “Tackling Mental Health Stigma” is the theme of a set of videos that are part of the Janssen Healthy Minds video series. The videos capture diverse ...
Interactions with Patient Organizations
Statement on Interactions with Patient Organizations Background In recent years, the role of the patient in the healthcare system has changed rapidly– from a recipient of care to an involved, educated and collaborative partner. As increasingly active ...
Creating Treatments for Infectious Diseases
Through science and innovation, we aim to protect, save and improve lives from infectious diseases. We’ve got a long history of doing more. From helping change the course of HIV and TB to developing vaccines for Ebola and COVID-19, we have been working ...
Janssen Develops Voice Technology Application for Clinical Trials
Janssen Develops Voice Technology Application for Clinical Trials Sep 02, 2020 Subhead: Lorem ipsum dolor sit amet, consectetuer adipiscing elit Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec ...
Our Mission to Develop a Global HIV Prevention Tool
Our Mission to Develop a Global HIV Prevention Tool Sep 24, 2020 Subhead: Lorem ipsum dolor sit amet, consectetuer adipiscing elit Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi ...
Is Expanded Access an Option Where I Live?
Is Expanded Access an Option Where I Live? Patients and advocates have asked me this question over the course of my career, especially those outside of the United States. The repetitive nature of the question shows there is an information gap regarding ...